» Articles » PMID: 31672759

Excess Mucus Viscosity and Airway Dehydration Impact COPD Airway Clearance

Overview
Journal Eur Respir J
Specialty Pulmonary Medicine
Date 2019 Nov 2
PMID 31672759
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

The mechanisms by which cigarette smoking impairs airway mucus clearance are not well understood. We recently established a ferret model of cigarette smoke-induced chronic obstructive pulmonary disease (COPD) exhibiting chronic bronchitis. We investigated the effects of cigarette smoke on mucociliary transport (MCT).Adult ferrets were exposed to cigarette smoke for 6 months, with mucociliary clearance measured by technetium-labelled DTPA retention. Excised tracheae were imaged with micro-optical coherence tomography. Mucus changes in primary human airway epithelial cells and ferret airways were assessed by histology and particle tracking microrheology. Linear mixed models for repeated measures identified key determinants of MCT.Compared to air controls, cigarette smoke-exposed ferrets exhibited mucus hypersecretion, delayed mucociliary clearance (-89.0%, p<0.01) and impaired tracheal MCT (-29.4%, p<0.05). Cholinergic stimulus augmented airway surface liquid (ASL) depth (5.8±0.3 to 7.3±0.6 µm, p<0.0001) and restored MCT (6.8±0.8 to 12.9±1.2 mm·min, p<0.0001). Mixed model analysis controlling for covariates indicated smoking exposure, mucus hydration (ASL) and ciliary beat frequency were important predictors of MCT. Ferret mucus was hyperviscous following smoke exposure or , and contributed to diminished MCT. Primary cells from smokers with and without COPD recapitulated these findings, which persisted despite the absence of continued smoke exposure.Cigarette smoke impairs MCT by inducing airway dehydration and increased mucus viscosity, and can be partially abrogated by cholinergic secretion of fluid secretion. These data elucidate the detrimental effects of cigarette smoke exposure on mucus clearance and suggest additional avenues for therapeutic intervention.

Citing Articles

Global scenario of silica-associated diseases: A review on emerging pathophysiology of silicosis and potential therapeutic regimes.

Sherekar P, Suke S, Dhok A, Malegaonkar S, Dhale S Toxicol Rep. 2025; 14:101941.

PMID: 39989982 PMC: 11847043. DOI: 10.1016/j.toxrep.2025.101941.


Comparison of a novel potentiator of CFTR channel activity to ivacaftor in ameliorating mucostasis caused by cigarette smoke in primary human bronchial airway epithelial cells.

Tanjala A, Jiang J, Eckford P, Ramjeesingh M, Li C, Huan L Respir Res. 2024; 25(1):269.

PMID: 38982492 PMC: 11234710. DOI: 10.1186/s12931-024-02889-w.


Effects of High Frequency Chest Wall Oscillation (HFCWO) on Clinical Symptoms in COPD.

Bruner M, Bazan C, Liu B, Cheng C, Chad M, Sievert C Res Sq. 2024; .

PMID: 38659871 PMC: 11042428. DOI: 10.21203/rs.3.rs-4165729/v1.


Inhaled immunoantimicrobials for the treatment of chronic obstructive pulmonary disease.

Zhu J, Li X, Zhou Y, Ge C, Li X, Hou M Sci Adv. 2024; 10(6):eabd7904.

PMID: 38324682 PMC: 10849584. DOI: 10.1126/sciadv.abd7904.


Accelerated Lung Function Decline and Mucus-Microbe Evolution in Chronic Obstructive Pulmonary Disease.

Meldrum O, Donaldson G, Narayana J, Ivan F, Jaggi T, Mac Aogain M Am J Respir Crit Care Med. 2024; 210(3):298-310.

PMID: 38315959 PMC: 11348959. DOI: 10.1164/rccm.202306-1060OC.


References
1.
Ermund A, Meiss L, Dolan B, Bahr A, Klymiuk N, Hansson G . The mucus bundles responsible for airway cleaning are retained in cystic fibrosis and by cholinergic stimulation. Eur Respir J. 2018; 52(2). PMC: 6247115. DOI: 10.1183/13993003.00457-2018. View

2.
Hajighasemi-Ossareh M, Borthwell R, Lachowicz-Scroggins M, Stevens J, Finkbeiner W, Widdicombe J . Distribution and size of mucous glands in the ferret tracheobronchial tree. Anat Rec (Hoboken). 2013; 296(11):1768-74. PMC: 4096109. DOI: 10.1002/ar.22783. View

3.
Morgan L, Pearson M, de Iongh R, Mackey D, Van der Wall H, Peters M . Scintigraphic measurement of tracheal mucus velocity in vivo. Eur Respir J. 2004; 23(4):518-22. DOI: 10.1183/09031936.04.00061404. View

4.
Serisier D, Carroll M, Shute J, Young S . Macrorheology of cystic fibrosis, chronic obstructive pulmonary disease & normal sputum. Respir Res. 2009; 10:63. PMC: 2712464. DOI: 10.1186/1465-9921-10-63. View

5.
Raju S, Lin V, Liu L, McNicholas C, Karki S, Sloane P . The Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor Augments Mucociliary Clearance Abrogating Cystic Fibrosis Transmembrane Conductance Regulator Inhibition by Cigarette Smoke. Am J Respir Cell Mol Biol. 2016; 56(1):99-108. PMC: 5248967. DOI: 10.1165/rcmb.2016-0226OC. View